A 57-years old female patient with systemic sclerosis underwent a prolonged intravenous therapy during 21 consecutive days with iloprost, a stable analogue of prostacyclin. Beginning with 0,5 ng/kg/minute the dose was increased every 2 days up to 2 ng/kg/minute. At the end of follow up, Iloprost was shown to enhance the perfusion of the finger and to improve pulmonary-function tests including the diffusion-capacity. Furthermore, the Erythrocyte Sedimentation Rate and the C-reactive protein decreased. The case report shows the necessity of a controlled study of prolonged iloprost therapy.
|Translated title of the contribution||Three week iloprost-therapy as an effective treatment of PSS - Case report and literature reference review|
|Journal||Zeitschrift fur Rheumatologie|
|Number of pages||7|
|Publication status||Published - 1998|
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)